CoAxia Overview

  • Founded
  • 1999
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 20
Employees
  • Latest Deal Type
  • M&A

CoAxia General Information

Description

Developer of blood flow controlling medical devices designed to treat cerebral ischemia. The company's neuroflo and flocontrol devices divert the blood flow of patients to the brain, enabling doctors to minimize the chances of stroke and heart attack in patients suffering from vasospasm and heart blockage.

Contact Information

Website
www.coaxia.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Acquirer
ZOLL Medical
Primary Office
  • 10900 73rd Avenue North
  • Suite 102
  • Maple Grove, MN 55369
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CoAxia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 01-Jul-2013 000.00 Completed Generating Revenue
4. Later Stage VC (Series D) 03-Mar-2011 000.00 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 02-Apr-2008 000.00 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 15-May-2002 $17.6M $22.6M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 17-Oct-2000 $4.98M $4.98M 000.00 Completed Startup
To view CoAxia’s complete valuation and funding history, request access »

CoAxia Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series C 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A1 531,342 $0.001000 $0.17 $2.1 $2.1 1x $2.1 0.29%
Series A 3,610,606 $0.001000 $0.17 $2.1 $2.1 1x $2.1 1.95%
To view CoAxia’s complete cap table history, request access »

CoAxia Patents

  • 31

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

CoAxia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20040006299-A1 Aortic shunt for selective cerebral perfusion in stroke and cardiac arrest Abandoned 07-Sep-2000 0000000000 00
US-6595963-B1 Aortic shunt for selective cerebral perfusion in stroke and cardiac arrest Expired - Lifetime 07-Sep-2000 0000000000 00
US-20050070838-A1 Intravascular spinal perfusion and cooling for use during aortic surgery Abandoned 31-Mar-1999 0000000000 00
US-20020058900-A1 Intravascular spinal perfusion and cooling for use during aortic surgery Granted 31-Mar-1999 0000000000 0
US-20070118095-A1 Cerebral perfusion augmentation Abandoned 01-Mar-1999 A61M25/0082
To view CoAxia’s complete patent history, request access »

CoAxia Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CoAxia Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Affinity Capital Management Venture Capital Minority 000 0000 000000 0
Baird Capital PE/Buyout Minority 000 0000 000000 0
Canaan Partners Venture Capital Minority 000 0000 000000 0
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority 000 0000 000000 0
New Harbor Venture Partners Growth/Expansion Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial